Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification

Table 1 General patients’ information

Character	Group definition	Total	EFI	Pelvis Only	P value
Age	≥65	17	2	15	0.001
Age	< 65	116	65	51	0.001
Pathology type	Squamous	122	63	59	0.332
Pathology type	Adenocarcinoma, Adeno/squamous Carcinoma	11	4	7	0.332
Tumor size	4 cm	33	18	15	0.581
Tumor size	≤ 4 cm	100	49	51	0.581
HGB prior treatment	< 110 g/L	36	22	14	0.144
HGB prior treatment	≥ 110 g/L	94	44	50	0.144
Concurrent chemotherapy	≥ 4 cycles	94	50	44	0.313
Concurrent chemotherapy	< 4 cycles	39	17	22	0.313
SCC-Ag	< 10	55	31	24	0.657
SCC-Ag	≥ 10	65	34	31	0.657
EQD2 (point A)	< 90Gy	16	4	12	0.091
	90–98 Gy	32	18	14
	≥ 98Gy	85	45	40
Therapy duration	≤ 63 days	111	55	56	0.669
Therapy duration	> 63 days	22	12	10	0.669

ISSN: 1748-717X